Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

Reid, 1976, Impaired red cell deformability in peripheral vascular disease, Lancet, 1, 666, 10.1016/S0140-6736(76)92778-1 Dormandy, 1979, Clinical importance of blood viscosity, Viscositas, 1, 5 Weed, 1970, The importance of erythrocyte deformability, Am J Med, 49, 147, 10.1016/S0002-9343(70)80069-9 Braasch, 1970, Red cell deformability and capillary blood flow, Physiol Rev, 51, 679, 10.1152/physrev.1971.51.4.679 Ehrly, 1976, altered deformability of erythrocytes from patients with chronic occlusive arterial disease, Vasa, 5, 319 Dormandy, 1973, Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication, Br Med J, 4, 576, 10.1136/bmj.4.5892.576 Imparato, 1975, Intermittent claudication: Its natural cause, Surgery, 78, 795 Barnes, 1981, Managing peripheral vascular disease, J Cardiovasc Med, 6, 33 Morris, 1977, Surgery and the progression of the occlusive process in patients with peripheral vascular disease, Radiology, 124, 343, 10.1148/124.2.343 Coffman, 1979, Vasodilator drugs in peripheral vascular disease, Med Intell, 300, 713 Hansteen, 1974, Vasodilator drugs in the treatment of peripheral arterial insufficiency, Acta Med Scand (suppl), 556, 9 1979, Federal Register, 44, 30436 Mueller, 1979, Pentoxifylline—a biomedical profile, J Med, 10, 307 Mueller, 1975, Zum Wirkungsmechanismus von Pentoxifylline (The mechanism of action of pentoxifylline), Med Monatsschr, 29, 487 La Celle, 1969, Alteration of deformability of erythrocyte membrane in stored blood, Transfusion, 9, 238, 10.1111/j.1537-2995.1969.tb04930.x Schmid-Schoenbein, 1969, Influence of deformability of human red cells upon blood viscosity, Circ Res, 25, 131, 10.1161/01.RES.25.2.131 Buzzi, 1976, Modifications of muscle blood flow produced by pentoxifylline in peripheral arterial occlusive disease, Pharmatherapeutica, 1, 234 Ehrly, 1979, The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease, J Med, 10, 331 Christ, 1972, Arzneimittelforsch, 22, 1933 Gastpar, 1977, Study of platelet aggregation in vivo. III. Effect of pentoxifylline, J Med, 8, 191 Angelkort, 1977, Influence of pentoxifylline (Trental 400) on microcirculation, poststenotic blood pressure and walking capacity in patients with chronic occlusive arterial disease, IRCS Med Sci, 5, 370 Feine-Haake, 1977, Fortschr Med, 95, 48 Buckert, 1976, Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests, Farmaco, 31, 264 Tonak, 1977, Zur Behandlung von Durchblutungsstoerungen mit Pentoxifyllin. Eine Doppelblindstudie mit Trental® (The treatment of circulatory disorders with pentoxifylline. A double-blind trial with Trental®, Med Monatsschr Pharm, 31, 467 Schubotz, 1976, Double-blind trial of pentoxifylline in diabetics with peripheral vascular disorders, Pharmatherapeutica, 1, 172 Bollinger, 1977, Double-blind study of pentoxifylline against placebo in patients with intermittent claudication, Pharmatherapeutica, 1, 557 Voelker, 1978, Behandlung von Arteriopathien mit Tranetal 400. Ergebnisse einer Doppelblindstudie (Treatment of arteriopathies with Trental 400. Results of a double-blind trial), Med Welt, 29, 1244 Winer, 1971 Mantel, 1963, Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure, J Am Stat Assoc, 58, 690